Literature DB >> 8354331

Mechanisms of tubulo-interstitial injury in progressive renal diseases.

L G Fine1, A C Ong, J T Norman.   

Abstract

A vast amount of evidence, based upon human renal biopsy material, indicates that the presence of tubular atrophy and interstitial fibrosis is a better indicator of outcome of renal function than is the extent of glomerular sclerosis. The pathophysiological basis for this surprising fact has not been adequately addressed. In this review we point out that the systemic hypertension which accompanies most forms of chronic renal disease could impact adversely upon the vasodilated interstitial vascular compartment which, together with a component of primary capillary injury related to the disease process, could cause progressive obliteration of particular capillaries. This would initiate a process of chronic tubular ischaemia ultimately leading to tubular atrophy. Since tubular cells have been shown to produce an array of cytokines and growth factors which modulate fibroblast proliferation, extracellular matrix production and chemo-attracts for infiltrating cells, it is further proposed that it is the tubular injury which initiates the deleterious cascade of events. Tubular injury may be aggravated by the filtration of potentially 'noxious' molecules through the diseased glomerulus and by infiltrating cells. As the vascular bed into which glomerular blood flow empties is progressively obliterated, glomerular function declines and renal failure advances in relation to the degree of tubulo-interstitial fibrosis.

Entities:  

Mesh:

Year:  1993        PMID: 8354331     DOI: 10.1111/j.1365-2362.1993.tb00771.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  Interactions between renal tubules and interstitium.

Authors:  A J Howie; C J Lote
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

2.  Glomerular and tubular function in glycogen storage disease.

Authors:  P J Lee; R N Dalton; V Shah; P C Hindmarsh; J V Leonard
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.

Authors:  Naro Ohashi; Sayaka Ishigaki; Kazuto Kitajima; Naoko Tsuji; Shinsuke Isobe; Takamasa Iwakura; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Akihiko Kato; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2014-12-21       Impact factor: 2.801

4.  Interstitial myofibroblasts: predictors of progression in membranous nephropathy.

Authors:  I S Roberts; C Burrows; J H Shanks; M Venning; L J McWilliam
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

5.  Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.

Authors:  Velidi H Rao; George E Lees; Clifford E Kashtan; Duane C Delimont; Rakesh Singh; Daniel T Meehan; Gautam Bhattacharya; Brian R Berridge; Dominic Cosgrove
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

6.  Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype.

Authors:  Gareth Thomas; Aled Clayton; Janet Thomas; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 7.  Regulating factors of renal tubular hypertrophy.

Authors:  G Wolf
Journal:  Clin Investig       Date:  1993-10

8.  Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.

Authors:  Sunfa Cheng; David H Lovett
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 9.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

10.  Hypoxia decreases podocyte expression of slit diaphragm proteins.

Authors:  Hong Lu; Gaurav Kapur; Tej K Mattoo; William D Lyman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.